Alert detail
FDA Approval: TIOCYSTIN (TIOPRONIN) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA212927Specialty: Multi-specialtyAdded: 6/6/2026Effective: 2026-06-02federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.